Red Tortoise LLC’s Kura Oncology KURA Stock Holding History

Red Tortoise LLC’s Portfolio KURA Stock Details KURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-119	Closed	-$1.46K	–	594
2023 Q1	$1.46K	Buy	+119	New	+$1.49K	﹤0.01%	497

Other funds holding KURA

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Red Tortoise LLC's KURA Position: Q2 2023 in Review

Red Tortoise LLC sold out of Kura Oncology (KURA) in Q2 2023, closing a stake of 119 shares — an estimated $1.46K sold.

Red Tortoise LLC first reported a position in KURA in Q1 2023 and held it in 1 quarter. The position peaked at $1.46K in Q1 2023. 148 funds tracked by Wall St. Rank hold KURA as of Q2 2023.

Red Tortoise LLC reported no remaining Kura Oncology position as of Q2 2023 after selling out during the quarter.
Red Tortoise LLC sold 119 Kura Oncology shares in Q2 2023, an estimated $1.46K.
Red Tortoise LLC first reported a position in Kura Oncology in Q1 2023 and held it in 1 quarter.
Red Tortoise LLC's Kura Oncology position peaked at $1.46K in Q1 2023.
148 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2023.

Based on Red Tortoise LLC's 13F filing for Q2 2023, filed 26 Jul 2023.